Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,986 | Dovepress* | 6,884+ | 1,425 | 8,309 | |
PubMed Central* | 102 | 48 | 150 | ||
Totals | 6,986 | 1,473 | 8,459 | ||
*Since 19 April 2017 |
View citations on PubMed Central and Google Scholar